Abstract:In recent years, the relationship between the microbiota and various aspects of health has become a focal point of scientific investigation. Although the most studied microbiota concern the gastrointestinal tract, recently, the interest has also been extended to other body districts. Female genital tract dysbiosis and its possible impact on pathologies such as endometriosis, polycystic ovary syndrome (PCOS), pelvic inflammatory disease (PID), and gynecological cancers have been unveiled. The incursion of pathogenic microbes alters the ecological equilibrium of the vagina, triggering inflammation and compromising immune defense, potentially fostering an environment conducive to cancer development. The most common types of gynecological cancer include cervical, endometrial, and ovarian cancer, which occur in women of any age but especially in postmenopausal women. Several studies highlighted that a low presence of lactobacilli at the vaginal level, and consequently, in related areas (such as the endometrium and ovary), correlates with a higher risk of gynecological pathology and likely contributes to increased incidence and worse prognosis of gynecological cancers. The complex interplay between microbial communities and the development, progression, and treatment of gynecologic malignancies is a burgeoning field not yet fully understood. The intricate crosstalk between the gut microbiota and systemic inflammation introduces a new dimension to our understanding of gynecologic cancers. The objective of this review is to focus attention on the association between vaginal microbiota and gynecological malignancies and provide detailed knowledge for future diagnostic and therapeutic strategies.

Gut and oral microbiota in gynecological cancers: interaction, mechanism, and therapeutic value

Vaginal and tumor microbiomes in gynecological cancer (Review)

The Oral-Gut Microbiome Axis in Breast Cancer: from Basic Research to Therapeutic Applications

Gut Microbes in Gynecologic Cancers: Causes or Biomarkers and Therapeutic Potential

The Microbiome and Gynecologic Cancer: Cellular Mechanisms and Clinical Applications

Gut microbiota influence tumor development and Alter interactions with the human immune system

Cervicovaginal and gastrointestinal microbiomes in gynecological cancers and their roles in therapeutic intervention

Host Mirnas-Microbiota Interactions in Gastric Cancer

Gastrointestinal Microbiota in Gastric Cancer: Potential Mechanisms and Clinical Applications—A Literature Review

Oral microbiome and its relationship with oral cancer

Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications

Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy

The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes

Insights into Pathogenesis and Therapy

Gut microbiota and its therapeutic implications in tumor microenvironment interactions

Microbiota in cancer: molecular mechanisms and therapeutic interventions

Oral Microbiota Associated with Oral and Gastroenteric Cancer

Gut microbes in gastrointestinal cancers

Oral microbiota and gastric cancer: recent highlights and knowledge gaps

Oral Microbiota and Tumor—A New Perspective of Tumor Pathogenesis

Host-Gut Microbiota Metabolic Interactions and Their Role in Precision Diagnosis and Treatment of Gastrointestinal Cancers